Abstract
The metastatic disease determines the cancer-specific death of most patients suggesting that decreasing the rate of metastasis should translate into increased cancer-specific survival. Several experiments in mice suggest that a major limiting step of the metastatic process is the ability of single cancer cells to proliferate at distant sites. Most dispersed cancer cells disseminated in distant organs seem to remain dormant for long period before eventually dying or resuming cell proliferation to give rise to micrometastases. The study of these dispersed dormant cells is made difficult by their rarity and the difficulty to isolate them into a viable cell population. Our recently published work shows that a dormant state can be easily induced in prostate cancer cells ex vivo in cell culture. Indeed, if and only if cells are cultured at low clonal density, slightly hypertonic conditions will induce a dormant state leading to an almost 1,000-fold reduction in clonogenicity. Our data suggest that a full dormant state is a stable anergic state actively generated in dispersed cells in response to specific growth conditions, and which may require special growth stimuli to be reversed. Here we compare this model with two examples of breast cancer cell dormancy induced in vitro in order to highlight their convergences and discuss the link between dormancy, epithelial-mesenchymal transition and stemness. We suggest that despite some similarities with stem cell dormancy, dormancy of epithelial cancer cells may be related to a reversible differentiation-like process. We also discuss the applications of the culture model of prostate cancer cell dormancy with emphasis on the development of new tools to fight the metastatic disease at the clonogenic step.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Armstrong AJ, Marengo MS, Oltean S, Kemeny G, Bitting RL, Turnbull JD, Herold CI, Marcom PK, George DJ, Garcia-Blanco MA (2011) Circulating tumor cells from patients with advanced prostate and breast cancer display both epithelial and mesenchymal markers. Mol Cancer Res 9:997–1007
Balk SP (2002) Androgen receptor as a target in androgen-independent prostate cancer. Urology 60:132–138
Barkan D, Kleinman H, Simmons JL, Asmussen H, Kamaraju AK, Hoenorhoff MJ, Liu ZY, Costes SV, Cho EH, Lockett S et al (2008) Inhibition of metastatic outgrowth from single dormant tumor cells by targeting the cytoskeleton. Cancer Res 68:6241–6250
Barkan D, El Touny LH, Michalowski AM, Smith JA, Chu I, Davis AS, Webster JD, Hoover S, Simpson RM, Gauldie J et al (2010) Metastatic growth from dormant cells induced by a col-I-enriched fibrotic environment. Cancer Res 70:5706–5716
Barrios J, Wieder R (2009) Dual fgf-2 and intergrin alpha5beta1 signaling mediate graf-induced rhoa inactivation in a model of breast cancer dormancy. Cancer Microenviron 2:33–47
Bissell DM, Arenson DM, Maher JJ, Roll FJ (1987) Support of cultured hepatocytes by a laminin-rich gel. Evidence for a functionally significant subendothelial matrix in normal rat liver. J Clin Invest 79:801–812
Braun S, Pantel K, Muller P, Janni W, Hepp F, Kentenich CR, Gastroph S, Wischnik A, Dimpfl T, Kindermann G et al (2000) Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II or III breast cancer. N Engl J Med 342:525–533
Cameron MD, Schmidt EE, Kerkvliet N, Nadkarni KV, Morris VL, Groom AC, Chambers AF, MacDonald IC (2000) Temporal progression of metastasis in lung: cell survival, dormancy, and location dependence of metastatic inefficiency. Cancer Res 60:2541–2546
Chao Y, Wu Q, Acquafondata M, Dhir R, Wells A (2011) Partial mesenchymal to epithelial reverting transition in breast and prostate cancer metastases. Cancer Microenviron 5:19–28
Danielpour D (1999) Transdifferentiation of nrp-152 rat prostatic basal epithelial cells toward a luminal phenotype: regulation by glucocorticoid, insulin-like growth factor-I and transforming growth factor-beta. J Cell Sci 112(Pt 2):169–179
Essers MA, Trumpp A (2010) Targeting leukemic stem cells by breaking their dormancy. Mol Oncol 4:443–450
Fenig E, Wieder R, Paglin S, Wang H, Persaud R, Haimovitz-Friedman A, Fuks Z, Yahalom J (1997) Basic fibroblast growth factor confers growth inhibition and mitogen-activated protein kinase activation in human breast cancer cells. Clin Cancer Res 3:135–142
Fenig E, Kanfi Y, Wang Q, Beery E, Livnat T, Wasserman L, Lilling G, Yahalom J, Wieder R, Nordenberg J (2001) Role of transforming growth factor beta in the growth inhibition of human breast cancer cells by basic fibroblast growth factor. Breast Cancer Res Treat 70:27–37
Gil-Bernabe AM, Ferjancic S, Tlalka M, Zhao L, Allen PD, Im JH, Watson K, Hill SA, Amirkhosravi A, Francis JL et al (2012) Recruitment of monocytes/macrophages by tissue factor-mediated coagulation is essential for metastatic cell survival and premetastatic niche establishment in mice. Blood 119:3164–3175
Havard M, Dautry F, Tchenio T (2011) A dormant state modulated by osmotic pressure controls clonogenicity of prostate cancer cells. J Biol Chem 286:44177–44186
Janni W, Rack B, Schindlbeck C, Strobl B, Rjosk D, Braun S, Sommer H, Pantel K, Gerber B, Friese K (2005) The persistence of isolated tumor cells in bone marrow from patients with breast carcinoma predicts an increased risk for recurrence. Cancer 103:884–891
Korah R, Boots M, Wieder R (2004) Integrin alpha5beta1 promotes survival of growth-arrested breast cancer cells: an in vitro paradigm for breast cancer dormancy in bone marrow. Cancer Res 64:4514–4522
Lee SO, Tian J, Huang CK, Ma Z, Lai KP, Hsiao H, Jiang M, Yeh S, Chang C (2012) Suppressor role of androgen receptor in proliferation of prostate basal epithelial and progenitor cells. J Endocrinol 213(2):173–182
Lindley LE, Briegel KJ (2010) Molecular characterization of TGFbeta-induced epithelial-mesenchymal transition in normal finite lifespan human mammary epithelial cells. Biochem Biophys Res Commun 399:659–664
Liu Y, Elf SE, Miyata Y, Sashida G, Liu Y, Huang G, Di Giandomenico S, Lee JM, Deblasio A, Menendez S et al (2009) p53 regulates hematopoietic stem cell quiescence. Cell Stem Cell 4:37–48
Luo Y, He DL, Ning L, Shen SL, Li L, Li X (2006) Hypoxia-inducible factor-1alpha induces the epithelial-mesenchymal transition of human prostate cancer cells. Chin Med J (Engl) 119:713–718
Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY, Brooks M, Reinhard F, Zhang CC, Shipitsin M et al (2008) The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133:704–715
Morel AP, Lievre M, Thomas C, Hinkal G, Ansieau S, Puisieux A (2008) Generation of breast cancer stem cells through epithelial-mesenchymal transition. PLoS One 3:e2888
Morris VL, Koop S, MacDonald IC, Schmidt EE, Grattan M, Percy D, Chambers AF, Groom AC (1994) Mammary carcinoma cell lines of high and low metastatic potential differ not in extravasation but in subsequent migration and growth. Clin Exp Metastasis 12:357–367
Najmi S, Korah R, Chandra R, Abdellatif M, Wieder R (2005) Flavopiridol blocks integrin-mediated survival in dormant breast cancer cells. Clin Cancer Res 11:2038–2046
Naumov GN, MacDonald IC, Weinmeister PM, Kerkvliet N, Nadkarni KV, Wilson SM, Morris VL, Groom AC, Chambers AF (2002) Persistence of solitary mammary carcinoma cells in a secondary site: a possible contributor to dormancy. Cancer Res 62:2162–2168
Naumov GN, Townson JL, MacDonald IC, Wilson SM, Bramwell VH, Groom AC, Chambers AF (2003) Ineffectiveness of doxorubicin treatment on solitary dormant mammary carcinoma cells or late-developing metastases. Breast Cancer Res Treat 82:199–206
Oltean S, Sorg BS, Albrecht T, Bonano VI, Brazas RM, Dewhirst MW, Garcia-Blanco MA (2006) Alternative inclusion of fibroblast growth factor receptor 2 exon IIIc in Dunning prostate tumors reveals unexpected epithelial mesenchymal plasticity. Proc Natl Acad Sci USA 103:14116–14121
Rak JW, McEachern D, Miller FR (1992) Sequential alteration of peanut agglutinin binding-glycoprotein expression during progression of murine mammary neoplasia. Br J Cancer 65:641–648
Salm SN, Burger PE, Coetzee S, Goto K, Moscatelli D, Wilson EL (2005) TGFbeta maintains dormancy of prostatic stem cells in the proximal region of ducts. J Cell Biol 170:81–90
Shibue T, Weinberg RA (2009) Integrin beta1-focal adhesion kinase signaling directs the proliferation of metastatic cancer cells disseminated in the lungs. Proc Natl Acad Sci USA 106:10290–10295
Ungefroren H, Sebens S, Groth S, Gieseler F, Fandrich F (2011) The src family kinase inhibitors pp2 and pp1 block TGFbeta1-mediated cellular responses by direct and differential inhibition of type I and type II TGFbeta receptors. Curr Cancer Drug Targets 11:524–535
van Leenders GJ, Schalken JA (2003) Epithelial cell differentiation in the human prostate epithelium: implications for the pathogenesis and therapy of prostate cancer. Crit Rev Oncol Hematol 46:S3–S10
Vessella RL, Pantel K, Mohla S (2007) Tumor cell dormancy: an nci workshop report. Cancer Biol Ther 6:1496–1504
Wells A, Yates C, Shepard CR (2008) E-cadherin as an indicator of mesenchymal to epithelial reverting transitions during the metastatic seeding of disseminated carcinomas. Clin Exp Metastasis 25:621–628
Wendt MK, Taylor MA, Schiemann BJ, Schiemann WP (2011) Down-regulation of epithelial cadherin is required to initiate metastatic outgrowth of breast cancer. Mol Biol Cell 22:2423–2435
Wiedswang G, Borgen E, Karesen R, Qvist H, Janbu J, Kvalheim G, Nesland JM, Naume B (2004) Isolated tumor cells in bone marrow three years after diagnosis in disease-free breast cancer patients predict unfavorable clinical outcome. Clin Cancer Res 10:5342–5348
Yamazaki S, Nakauchi H (2009) Insights into signaling and function of hematopoietic stem cells at the single-cell level. Curr Opin Hematol 16:255–258
Acknowledgements
The author is grateful to Dr. François Dautry for his critical reading of the manuscript and helpful comments. Most of the work on prostate cancer cell dormancy was conducted in the laboratory of Dr. François Dautry.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Tchénio, T. (2013). Clonogenicity of Cultured Prostate Cancer Cells Is Controlled by Dormancy: Significance and Comparison with Cell Culture Models of Breast Cancer Cell Dormancy. In: Hayat, M. (eds) Tumor Dormancy, Quiescence, and Senescence, Volume 1. Tumor Dormancy and Cellular Quiescence and Senescence, vol 1. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-5958-9_5
Download citation
DOI: https://doi.org/10.1007/978-94-007-5958-9_5
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-007-5957-2
Online ISBN: 978-94-007-5958-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)